Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

This publication has 13 references indexed in Scilit:

• Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk
  Journal of Travel Medicine, 2009
• Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
  Vaccine, 2009
• Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51
  Vaccine, 2008
• Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Trial of the Safety and Tolerability of IC51, an Inactivated Japanese Encephalitis Vaccine
  The Journal of Infectious Diseases, 2008
• Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51
  Vaccine, 2008
• Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
  The Lancet, 2007
• A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis
  Vaccine, 2007
• Control of Japanese Encephalitis — Within Our Grasp?
  New England Journal of Medicine, 2006
• Persistence of protective immunity following vaccination against tick-borne encephalitis—longer than expected?
  Vaccine, 2004
• Vaccination against Hepatitis B: Comparison of Three Different Vaccination Schedules
  The Journal of Infectious Diseases, 1989